One of their latest challenges is managing the vaccine rollout for children under 5, which could begin in weeks — and educating parents and caretakers about the importance of vaccination.
NPR’s Rob Stein reports on another persistent public health challenge: long COVID. A recent study offers some clues about why many people suffer from symptoms for months. Rob also spoke to Gregory Glenn of Novavax, who you’ll hear in this episode discussing the company’s new COVID vaccine, which is awaiting FDA authorization.
Help NPR improve podcasts by completing a short, anonymous survey at npr.org/podcastsurvey.
Email us at considerthis@npr.org.